港股異動 | 三大電信股全線上漲 中國移動(0941.HK)漲超3%
格隆匯1月14日丨三大電信股全線上漲,中國移動(0941.HK)漲超3%,中國電信、中國聯通均漲超2%。據悉,南下資金昨日淨買入港股119.07億港元,連續8個交易日淨買入額在百億港元以上。其中,港股通已連續11個交易日淨買入中國移動累計約344.54億港元。此外,盈富基金管理人道富環球13日公佈,盈富基金將於1月14日(即今日)起恢復對屬於恆生指數成份股公司的受制裁實體進行投資。因美國政府的禁令,道富環球曾在1月11日宣佈不再將盈富基金投資在中國移動、中國聯通及中海油三間中資公司。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.